IAPP and type 2 diabetes mellitus: Along with insulin, therapeutic replacement of amylin, as originally suggested [34], is nowadays recommended for a more tight control of glycemia in individuals with either type 1 or type 2 diabetes mellitus (T1DM or T2DM, respectively) [10,33,35–41].